Literature DB >> 21906814

Metastatic choroidal paraganglioma.

Ann Schalenbourg1, Alexandre Moulin, Louis Guillou, Leonidas Zografos.   

Abstract

PURPOSE: To describe a patient with metastatic choroidal paraganglioma that was locally controlled with radiotherapy.
DESIGN: Interventional clinicopathologic case report. PARTICIPANT: One patient with metastatic choroidal paraganglioma.
METHODS: Interventional clinicopathologic case report and systematic search of the literature. MAIN OUTCOME MEASURES: Description of clinicopathologic features, treatment methods, and outcome.
RESULTS: A 50-year-old man had a nonpigmented atypical choroidal mass with secondary retinal detachment in the left eye. After incisional biopsy, the diagnosis of paraganglioma was established. Metastatic work-up revealed vertebral, mediastinal, and pulmonary metastases of a nonsecretory, malignant paraganglioma without tracer uptake. The primary tumor was not identified. The ocular tumor regressed after stereotaxic radiotherapy. Two years later, recurrent lesions developed in the contralateral eye, which also was irradiated.
CONCLUSIONS: Malignant paraganglioma can metastasize in the choroid and should be included in the differential diagnosis of a nonpigmented choroidal mass. Stereotaxic radiation therapy is an effective treatment method. To the authors' knowledge, this is the first report of a patient with choroidal paraganglioma. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906814     DOI: 10.1016/j.ophtha.2011.04.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  1 in total

1.  Choroidal paraganglioma with metastases to the fellow eye.

Authors:  Rita Van Ginderdeuren; Guy S Missotten; Joost van den Oord
Journal:  Case Rep Ophthalmol       Date:  2013-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.